Artrya Limited (ASX:AYA), a medical technology company commercialising its Salix® AI-powered cloud platform for coronary artery disease assessment, has entered a five-year commercial agreement with Arizona health system HonorHealth, carrying a minimum contracted value of US$0.5 million.

Key Points

  • Five-year commercial agreement with HonorHealth carries a minimum contracted value of US$0.5 million for Salix® Coronary Anatomy
  • HonorHealth is Artrya's fifth U.S. commercial customer and first secured outside foundation customers and SAPPHIRE study participants
  • HonorHealth operates nine acute-care hospitals across the Phoenix and Scottsdale areas, serving approximately five million people
  • Additional fee-per-scan revenue from Salix® Coronary Plaque and Salix® Coronary Flow modules is possible following FDA clearance, beyond the minimum contracted value

Agreement Terms and Revenue Structure

The five-year agreement provides for recurring SaaS subscription revenue from Salix® Coronary Anatomy, with the US$0.5 million minimum contracted value applying to that module only. Additional usage-based revenue may be generated from assessments performed with the Salix® Coronary Plaque module and, following FDA clearance, the Salix® Coronary Flow module. The agreement includes standard provisions for events of default, along with customary terms covering security and privacy protocols, support levels, and software upgrades. The filing states no estimates of CCTA scan numbers are provided. Artrya described HonorHealth as its second largest customer under the agreement.

HonorHealth Network Deployment

Salix® is to be deployed across HonorHealth's network of nine acute-care hospitals, each of which provides coronary CT angiography (CCTA) scans across the greater Phoenix and Scottsdale metropolitan areas. HonorHealth is one of Arizona's largest non-profit healthcare systems, serving a population of approximately five million people. The health system's HonorHealth Heart Care network includes 40 cardiac specialist offices. HonorHealth is also the primary clinical affiliate of Arizona State University John Shufeldt School of Medicine and Medical Engineering, which the filing states creates opportunities for future clinical research and innovation.

Cardiovascular Imaging Centre of Excellence Plans

HonorHealth has outlined an ambition to develop a leading CCTA program in Arizona. The disclosed pathway envisages an initial focus on embedding Salix® into clinical workflows, followed by growth in physician adoption, CCTA capacity, and use of the platform's coronary assessment modules. Over the longer term, HonorHealth and Artrya stated they intend to explore the development of a recognised cardiovascular imaging Centre of Excellence, potentially supporting real-world clinical evidence, education, training, and a reference model for broader U.S. adoption. Artrya's engagement team for the agreement included technical, clinical, and information technology disciplines.